Literature DB >> 26639031

Influence of demographic and clinical factors on the mortality rate of a rheumatoid arthritis cohort: A 20-year survival study.

Lydia Abasolo1, Jose Ivorra-Cortes2, Leticia Leon3, Juan A Jover3, Benjamin Fernandez-Gutierrez3, Luis Rodriguez-Rodriguez3.   

Abstract

OBJECTIVES: To describe the mortality rate (MR) and standardized MR (SMR) of an incident cohort of rheumatoid arthritis (RA) patients followed up for 20 years, and to analyze the influence on morality risk of different demographic and clinical variables, including radiographic joint damage.
METHODS: Retrospective longitudinal study that included 2271 RA patients attending the rheumatology outpatient clinic of the Hospital Clínico San Carlos (Madrid, Spain), enrolled from January 1994 to February 2013 and followed up from RA diagnosis to patients׳ death or September 2013. Disability and disease activity were measured as the averaged value of the Heath Assessment Questionnaire and the erythrocyte sedimentation rate, respectively, of the first 2 years after RA diagnosis. Radiographic joint damage of hands and wrists was assessed with the Sharp/van der Heijde score. Indirect SMRs with a 95% of confidence interval (95% CI) were calculated. Cox bivariate and multivariate regression models were performed to assess risk factors for death.
RESULTS: A total of 431 patients died (19%) during the observation time (18,482 person-years), resulting in a MR of 23 subjects per 1000 patient-years [95% CI: 21-26]. SMR was 1.89 (1.72-2.08). In the multivariate analysis, men, older age at diagnosis, the presence of rheumatoid factor, higher number of hospital admissions, greater disease activity, and greater radiographic joint damage were independently associated with greater mortality risk.
CONCLUSIONS: RA patients have an excess mortality compared with the general population. Radiological joint damage and early disease activity are independent mortality risk factors. A tighter control at early stages may be necessary to reduce mortality.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Mortality; Radiographic joint damage; Rheumatoid arthritis; Survival analysis

Mesh:

Year:  2015        PMID: 26639031     DOI: 10.1016/j.semarthrit.2015.10.016

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  10 in total

Review 1.  [Treat to target and personalized medicine (precision medicine)].

Authors:  J Detert; G R Burmester
Journal:  Z Rheumatol       Date:  2016-08       Impact factor: 1.372

2.  Contribution of the bone and cartilage/soft tissue components of the joint damage to the level of disability in rheumatoid arthritis patients: a longitudinal study.

Authors:  Lydia Abasolo; Jose Ivorra-Cortes; Leticia Leon; Juan A Jover; Benjamín Fernández-Gutiérrez; Luis Rodriguez-Rodriguez
Journal:  Clin Rheumatol       Date:  2018-10-16       Impact factor: 2.980

Review 3.  Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.

Authors:  Vicente Ruiz Garcia; Amanda Burls; Juan B Cabello; Paloma Vela Casasempere; Sylvia Bort-Marti; José A Bernal
Journal:  Cochrane Database Syst Rev       Date:  2017-09-08

4.  Rate of Proven Rheumatic Diseases in a Large Collective of Referrals to an Outpatient Rheumatology Clinic Under Routine Conditions.

Authors:  Martin Feuchtenberger; Axel Philipp Nigg; Michael Rupert Kraus; Arne Schäfer
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2016-10-02

5.  Development and validation of a multivariate predictive model for rheumatoid arthritis mortality using a machine learning approach.

Authors:  José M Lezcano-Valverde; Fernando Salazar; Leticia León; Esther Toledano; Juan A Jover; Benjamín Fernandez-Gutierrez; Eduardo Soudah; Isidoro González-Álvaro; Lydia Abasolo; Luis Rodriguez-Rodriguez
Journal:  Sci Rep       Date:  2017-08-31       Impact factor: 4.379

6.  Long-Term Increase of Radiographic Damage and Disability in Patients with RA in Relation to Disease Duration in the Era of Biologics. Results from the SCQM Cohort.

Authors:  Katja Heinimann; Johannes von Kempis; Rafael Sauter; Michael Schiff; Tuulikki Sokka-Isler; Hendrik Schulze-Koops; Rüdiger Müller
Journal:  J Clin Med       Date:  2018-03-13       Impact factor: 4.241

7.  Mortality in Inflammatory Rheumatic Diseases: Lithuanian National Registry Data and Systematic Review.

Authors:  Jolanta Dadonienė; Greta Charukevič; Gabija Jasionytė; Karolina Staškuvienė; Dalia Miltinienė
Journal:  Int J Environ Res Public Health       Date:  2021-11-24       Impact factor: 3.390

Review 8.  Rheumatoid arthritis and risk of cardiovascular disease.

Authors:  Pieter W Meyer; Ronald Anderson; James A Ker; Mahmood T Ally
Journal:  Cardiovasc J Afr       Date:  2018-03-27       Impact factor: 1.167

9.  Mortality rate in rheumatoid arthritis-related interstitial lung disease: the role of radiographic patterns.

Authors:  Maria A Nieto; Maria J Rodriguez-Nieto; Olga Sanchez-Pernaute; Fredeswinda Romero-Bueno; Leticia Leon; Cristina Vadillo; Dalifer D Freites-Nuñez; Juan A Jover; Jose L Álvarez-Sala; Lydia Abasolo
Journal:  BMC Pulm Med       Date:  2021-06-30       Impact factor: 3.317

10.  A predominant involvement of the triple seropositive patients and others with rheumatoid factor in the association of smoking with rheumatoid arthritis.

Authors:  Cristina Regueiro; Luis Rodriguez-Rodriguez; Raquel Lopez-Mejias; Laura Nuño; Ana Triguero-Martinez; Eva Perez-Pampin; Alfonso Corrales; Alejandro Villalba; Yolanda Lopez-Golan; Lydia Abasolo; Sara Remuzgo-Martínez; Ana M Ortiz; Eva Herranz; Ana Martínez-Feito; Carmen Conde; Antonio Mera-Varela; Alejandro Balsa; Isidoro Gonzalez-Alvaro; Miguel Ángel González-Gay; Benjamín Fernandez-Gutierrez; Antonio Gonzalez
Journal:  Sci Rep       Date:  2020-02-25       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.